Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""cognitive impairment."" wg kryterium: Temat


Tytuł:
Chemotherapy-induced cognitive impairment in breast cancer survivors: A systematic review of studies from 2000 to 2021.
Autorzy:
Amani O; Department of Psychology, Shahid Beheshti University, Tehran, Iran.
Mazaheri MA; Department of Psychology, Shahid Beheshti University, Tehran, Iran.
Moghani MM; Department of Radiation Oncology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Zarani F; Department of Psychology, Shahid Beheshti University, Tehran, Iran.
Choolabi RH; Department of Psychology, Ahrar Institute of Technology and Higher Education, Rasht, Iran.
Pokaż więcej
Źródło:
Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2024 Feb; Vol. 7 (2), pp. e1989.
Typ publikacji:
Systematic Review; Journal Article; Review
MeSH Terms:
Breast Neoplasms*/complications
Cancer Survivors*/psychology
Chemotherapy-Related Cognitive Impairment*/etiology
Chemotherapy-Related Cognitive Impairment*/complications
Cognitive Dysfunction*/chemically induced
Cognitive Dysfunction*/diagnosis
Humans ; Female ; Quality of Life
Czasopismo naukowe
Tytuł:
Prevalence and associated factors of chemotherapy-related cognitive impairment in older breast cancer survivors.
Autorzy:
Zhou X; Jilin University School of Nursing, Changchun, China.
Zhang X; Jilin University School of Nursing, Changchun, China.
Zhong T; Jilin University School of Nursing, Changchun, China.
Zhou M; Jilin University School of Nursing, Changchun, China.
Gao L; The First Hospital of Jilin University, Changchun, China.
Chen L; Jilin University School of Nursing, Changchun, China.
Pokaż więcej
Źródło:
Journal of advanced nursing [J Adv Nurs] 2024 Feb; Vol. 80 (2), pp. 484-499. Date of Electronic Publication: 2023 Sep 07.
Typ publikacji:
Systematic Review; Journal Article; Review
MeSH Terms:
Cancer Survivors*
Chemotherapy-Related Cognitive Impairment*
Breast Neoplasms*/drug therapy
United States ; Humans ; Aged ; Female ; Prevalence ; Life Style
Czasopismo naukowe
Tytuł:
More than a small adult brain: Lessons from chemotherapy-induced cognitive impairment for modelling paediatric brain disorders.
Autorzy:
Davies MR; School of Biomedicine, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia; Supportive Oncology Research Group, Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia. Electronic address: .
Greenberg Z; South Australian Health and Medical Research Institute (SAHMRI), Laboratory of Human Neurophysiology and Genetics, Adelaide, SA, Australia.
van Vuurden DG; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, the weNetherlands.
Cross CB; Supportive Oncology Research Group, Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia.
Zannettino ACW; School of Biomedicine, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.
Bardy C; South Australian Health and Medical Research Institute (SAHMRI), Laboratory of Human Neurophysiology and Genetics, Adelaide, SA, Australia; Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
Wardill HR; School of Biomedicine, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia; Supportive Oncology Research Group, Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia.
Pokaż więcej
Źródło:
Brain, behavior, and immunity [Brain Behav Immun] 2024 Jan; Vol. 115, pp. 229-247. Date of Electronic Publication: 2023 Oct 18.
Typ publikacji:
Review; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Chemotherapy-Related Cognitive Impairment*
Neoplasms*
Brain Diseases*
Adult ; Child ; Humans ; Brain
Czasopismo naukowe
Tytuł:
Chemobrain in blood cancers: How chemotherapeutics interfere with the brain's structure and functionality, immune system, and metabolic functions.
Autorzy:
Skurlova M; Department of Experimental Psychopharmacology, National Institute of Mental Health, Klecany, Czech Republic.
Holubova K; Department of Experimental Psychopharmacology, National Institute of Mental Health, Klecany, Czech Republic.
Kleteckova L; Department of Experimental Psychopharmacology, National Institute of Mental Health, Klecany, Czech Republic.
Kozak T; Department of Developmental Epileptology, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
Kubova H; Department of Internal Medicine and Hematology, Faculty Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
Horacek J; Department of Experimental Psychopharmacology, National Institute of Mental Health, Klecany, Czech Republic.
Vales K; Department of Experimental Psychopharmacology, National Institute of Mental Health, Klecany, Czech Republic.
Pokaż więcej
Źródło:
Medicinal research reviews [Med Res Rev] 2024 Jan; Vol. 44 (1), pp. 5-22. Date of Electronic Publication: 2023 Jun 02.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Chemotherapy-Related Cognitive Impairment*/metabolism
Chemotherapy-Related Cognitive Impairment*/pathology
Neoplasms*/drug therapy
Hematologic Neoplasms*/metabolism
Hematologic Neoplasms*/pathology
Animals ; Humans ; Brain/metabolism ; Immune System
Czasopismo naukowe
Tytuł:
Senolytic treatment alleviates doxorubicin-induced chemobrain.
Autorzy:
Budamagunta V; Department of Neuroscience, McKnight Brain Institute, University of Florida, Gainesville, Florida, USA.; Genetics and Genomics Graduate Program, Genetics Institute, University of Florida, Gainesville, Florida, USA.; Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, Florida, USA.
Kumar A; Department of Neuroscience, McKnight Brain Institute, University of Florida, Gainesville, Florida, USA.
Rani A; Department of Neuroscience, McKnight Brain Institute, University of Florida, Gainesville, Florida, USA.
Manohar Sindhu S; Genetics and Genomics Graduate Program, Genetics Institute, University of Florida, Gainesville, Florida, USA.
Yang Y; Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, Florida, USA.
Zhou D; Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, Florida, USA.; Department of Biochemistry and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
Foster TC; Department of Neuroscience, McKnight Brain Institute, University of Florida, Gainesville, Florida, USA.; Genetics and Genomics Graduate Program, Genetics Institute, University of Florida, Gainesville, Florida, USA.
Pokaż więcej
Źródło:
Aging cell [Aging Cell] 2024 Feb; Vol. 23 (2), pp. e14037. Date of Electronic Publication: 2024 Jan 15.
Typ publikacji:
Journal Article
MeSH Terms:
Chemotherapy-Related Cognitive Impairment*
Sulfonamides*
Humans ; Senotherapeutics ; Doxorubicin/adverse effects ; Aniline Compounds ; Cellular Senescence
Czasopismo naukowe
Tytuł:
Nrf2 Signaling Pathway: a Potential Therapeutic Target in Combating Oxidative Stress and Neurotoxicity in Chemotherapy-Induced Cognitive Impairment.
Autorzy:
Lal R; Pharmacology Division, University Institute of Pharmaceutical Sciences (UIPS), Panjab University, Chandigarh, 160014, India.
Dharavath RN; Pharmacology Division, University Institute of Pharmaceutical Sciences (UIPS), Panjab University, Chandigarh, 160014, India.; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, M5T 1R8, Canada.
Chopra K; Pharmacology Division, University Institute of Pharmaceutical Sciences (UIPS), Panjab University, Chandigarh, 160014, India. dr_chopra_.
Pokaż więcej
Źródło:
Molecular neurobiology [Mol Neurobiol] 2024 Feb; Vol. 61 (2), pp. 593-608. Date of Electronic Publication: 2023 Aug 29.
Typ publikacji:
Journal Article; Review
MeSH Terms:
NF-E2-Related Factor 2*/metabolism
Chemotherapy-Related Cognitive Impairment*
Humans ; Neuroinflammatory Diseases ; Quality of Life ; Oxidative Stress ; Signal Transduction
Czasopismo naukowe
Tytuł:
A Drosophila model relevant to chemotherapy-related cognitive impairment.
Autorzy:
Torre M; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA, 02115, USA.
Bukhari H; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA, 02115, USA.
Nithianandam V; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA, 02115, USA.
Zanella CA; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA, 02115, USA.
Mata DA; Foundation Medicine, Inc., Cambridge, MA, USA.
Feany MB; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA, 02115, USA. mel_.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Nov 07; Vol. 13 (1), pp. 19290. Date of Electronic Publication: 2023 Nov 07.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Agents*/adverse effects
Cognitive Dysfunction*/diagnosis
Chemotherapy-Related Cognitive Impairment*
Adult ; Animals ; Humans ; Cisplatin/adverse effects ; Drosophila ; Doxorubicin/adverse effects
Czasopismo naukowe
Tytuł:
Phytochemical profiling and neuroprotective activity of Callistemon subulatus leaves against cyclophosphamide-induced chemobrain.
Autorzy:
Rabie O; Department of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Abbassia, Cairo 11566, Egypt.
El-Nashar HAS; Department of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Abbassia, Cairo 11566, Egypt.
George MY; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, 11566 Cairo, Egypt.
Majrashi TA; Department of Pharmacognosy, College of Pharmacy, King Khalid University, Asir 61421, Saudi Arabia.
Al-Warhi T; Department of Chemistry, College of Science, Princess Nourah Bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.
Hassan FE; Department of Physiology, General Medicine Practice Program, Batterjee Medical College, Jeddah 21442, Saudi Arabia; Medical Physiology Department, Kasr Alainy, Faculty of Medicine, Cairo University, Giza 11562, Egypt.
Eldehna WM; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University, P.O. Box 33516, Kafrelsheikh, Egypt. Electronic address: .
Mostafa NM; Department of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Abbassia, Cairo 11566, Egypt. Electronic address: .
Pokaż więcej
Źródło:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2023 Nov; Vol. 167, pp. 115596. Date of Electronic Publication: 2023 Oct 03.
Typ publikacji:
Journal Article
MeSH Terms:
Chemotherapy-Related Cognitive Impairment*
Neuroprotective Agents*/pharmacology
Humans ; Rats ; Animals ; Acetylcholinesterase/metabolism ; Antioxidants/pharmacology ; Antioxidants/metabolism ; Oxidative Stress ; Cyclophosphamide/toxicity
Czasopismo naukowe
Tytuł:
Accelerated cerebromicrovascular senescence contributes to cognitive decline in a mouse model of paclitaxel (Taxol)-induced chemobrain.
Autorzy:
Ahire C; Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Nyul-Toth A; Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.; International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Departments of Public Health and Translational Medicine, Semmelweis University, Budapest, Hungary.; International Training Program in Geroscience, Institute of Biophysics, Biological Research Centre, ELKH, Szeged, Hungary.
DelFavero J; Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Gulej R; Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Faakye JA; Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Tarantini S; Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.; International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Departments of Public Health and Translational Medicine, Semmelweis University, Budapest, Hungary.; Department of Health Promotion Sciences, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.; The Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Kiss T; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.; International Training Program in Geroscience, First Department of Pediatrics, Semmelweis University, Budapest, Hungary.
Kuan-Celarier A; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.; The Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Balasubramanian P; Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.; The Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Ungvari A; Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.; International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Departments of Public Health and Translational Medicine, Semmelweis University, Budapest, Hungary.
Tarantini A; Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.; International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Departments of Public Health and Translational Medicine, Semmelweis University, Budapest, Hungary.; The Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Nagaraja R; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Yan F; Stephenson School of Biomedical Engineering, Gallogly College of Engineering, The University of Oklahoma, Norman, Oklahoma, USA.
Tang Q; Stephenson School of Biomedical Engineering, Gallogly College of Engineering, The University of Oklahoma, Norman, Oklahoma, USA.
Mukli P; Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.; International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Departments of Public Health and Translational Medicine, Semmelweis University, Budapest, Hungary.
Csipo T; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.; International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Departments of Public Health and Translational Medicine, Semmelweis University, Budapest, Hungary.
Yabluchanskiy A; Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.; Department of Health Promotion Sciences, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.; The Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Campisi J; Buck Institute for Research on Aging, Novato, California, USA.
Ungvari Z; Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.; International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Departments of Public Health and Translational Medicine, Semmelweis University, Budapest, Hungary.; Department of Health Promotion Sciences, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.; The Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Csiszar A; Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.; Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.; International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Departments of Public Health and Translational Medicine, Semmelweis University, Budapest, Hungary.; The Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Pokaż więcej
Źródło:
Aging cell [Aging Cell] 2023 Jul; Vol. 22 (7), pp. e13832. Date of Electronic Publication: 2023 May 26.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Chemotherapy-Related Cognitive Impairment*
Cognitive Dysfunction*
Mice ; Animals ; Endothelial Cells ; Paclitaxel/adverse effects ; Senotherapeutics ; Disease Models, Animal
Czasopismo naukowe
Tytuł:
"Chemobrain" in childhood cancer survivors-the impact on social, academic, and daily living skills: a qualitative systematic review.
Autorzy:
Semendric I; School of Biomedicine, The University of Adelaide, Adelaide, South Australia, Australia. .
Pollock D; Health Evidence Synthesis, Recommendations and Impact (HESRI), School of Public Health, The University of Adelaide, Adelaide, South Australia, Australia.
Haller OJ; School of Biomedicine, The University of Adelaide, Adelaide, South Australia, Australia.
George RP; School of Biomedicine, The University of Adelaide, Adelaide, South Australia, Australia.
Collins-Praino LE; School of Biomedicine, The University of Adelaide, Adelaide, South Australia, Australia.
Whittaker AL; School of Animal and Veterinary Sciences, The University of Adelaide, Roseworthy, South Australia, Australia.
Pokaż więcej
Źródło:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2023 Aug 22; Vol. 31 (9), pp. 532. Date of Electronic Publication: 2023 Aug 22.
Typ publikacji:
Systematic Review; Journal Article; Review
MeSH Terms:
Cancer Survivors*
Chemotherapy-Related Cognitive Impairment*
Neoplasms*/drug therapy
Cognitive Dysfunction*/chemically induced
Child ; Humans ; Survivors
Czasopismo naukowe
Tytuł:
A Clinically Relevant Dosage of Mitoxantrone Disrupts the Glutathione and Lipid Metabolic Pathways of the CD-1 Mice Brain: A Metabolomics Study.
Autorzy:
Dias-Carvalho A; Associate Laboratory i4HB, Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.; UCIBIO-Applied Molecular Biosciences Unit, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
Margarida-Araújo A; Associate Laboratory i4HB, Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.; UCIBIO-Applied Molecular Biosciences Unit, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
Reis-Mendes A; Associate Laboratory i4HB, Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.; UCIBIO-Applied Molecular Biosciences Unit, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
Sequeira CO; iNOVA4Health, LS4Future, NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM), Universidade Nova de Lisboa, 1150-082 Lisboa, Portugal.
Pereira SA; iNOVA4Health, LS4Future, NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM), Universidade Nova de Lisboa, 1150-082 Lisboa, Portugal.
Guedes de Pinho P; Associate Laboratory i4HB, Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.; UCIBIO-Applied Molecular Biosciences Unit, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
Carvalho F; Associate Laboratory i4HB, Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.; UCIBIO-Applied Molecular Biosciences Unit, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
Sá SI; Unit of Anatomy, Department of Biomedicine, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.; Center for Health Technology and Services Research (CINTESIS), Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.
Fernandes E; LAQV-REQUIMTE, Laboratory of Applied Chemistry, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
Costa VM; Associate Laboratory i4HB, Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.; UCIBIO-Applied Molecular Biosciences Unit, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Aug 23; Vol. 24 (17). Date of Electronic Publication: 2023 Aug 23.
Typ publikacji:
Journal Article
MeSH Terms:
Mitoxantrone*
Chemotherapy-Related Cognitive Impairment*
Male ; Animals ; Mice ; Metabolomics ; Glutathione ; Brain ; Metabolic Networks and Pathways ; Lipids
Czasopismo naukowe
Tytuł:
Managing Cancer and Living Meaningfully (CALM) alleviates chemotherapy related cognitive impairment (CRCI) in breast cancer survivors: A pilot study based on resting-state fMRI.
Autorzy:
Yao S; Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.; Cancer and Cognition Laboratory, Anhui Medical University, Hefei, China.
Zhu Q; Department of Radiology, Quzhou People's Hospital, Quzhou, China.
Zhang Q; Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.; Cancer and Cognition Laboratory, Anhui Medical University, Hefei, China.
Cai Y; Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.; Cancer and Cognition Laboratory, Anhui Medical University, Hefei, China.
Liu S; Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.; Cancer and Cognition Laboratory, Anhui Medical University, Hefei, China.
Pang L; Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.; Cancer and Cognition Laboratory, Anhui Medical University, Hefei, China.
Jing Y; Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.; Cancer and Cognition Laboratory, Anhui Medical University, Hefei, China.
Yin X; Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.; Cancer and Cognition Laboratory, Anhui Medical University, Hefei, China.
Cheng H; Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.; Shenzhen Clinical Medical School of Southern Medical University, Shenzhen, China.; Department of Oncology, Shenzhen Hospital of Southern Medical University, Shenzhen, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Aug; Vol. 12 (15), pp. 16231-16242. Date of Electronic Publication: 2023 Jul 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Breast Neoplasms*/drug therapy
Chemotherapy-Related Cognitive Impairment*
Cancer Survivors*
Percutaneous Coronary Intervention*
Humans ; Female ; Magnetic Resonance Imaging/methods ; Pilot Projects ; Quality of Life ; Brain/diagnostic imaging
Czasopismo naukowe
Tytuł:
Advances of neuroimaging in chemotherapy related cognitive impairment (CRCI) of patients with breast cancer.
Autorzy:
Yao S; Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.; Cancer and Cognition Laboratory, Anhui Medical University, Hefei, Anhui, China.
Zhang Q; Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.; Cancer and Cognition Laboratory, Anhui Medical University, Hefei, Anhui, China.
Yao X; Hefei Cancer Hospital, Chinese Academy of Sciences, Hefei, Anhui, China.
Zhang X; Hefei Cancer Hospital, Chinese Academy of Sciences, Hefei, Anhui, China.
Pang L; Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.; Cancer and Cognition Laboratory, Anhui Medical University, Hefei, Anhui, China.
Yu S; Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.; Cancer and Cognition Laboratory, Anhui Medical University, Hefei, Anhui, China.
Cheng H; Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China. .; Department of Oncology, Shenzhen Hospital of Southern Medical University, Shenzhen, Guangdong, China. .; Shenzhen Clinical Medical School, Southern Medical University, Shenzhen, Guangdong, China. .
Pokaż więcej
Źródło:
Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Aug; Vol. 201 (1), pp. 15-26. Date of Electronic Publication: 2023 Jun 17.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Breast Neoplasms*/complications
Breast Neoplasms*/drug therapy
Cognitive Dysfunction*/diagnostic imaging
Cognitive Dysfunction*/etiology
Chemotherapy-Related Cognitive Impairment*/complications
Humans ; Female ; Quality of Life ; Neuroimaging
Czasopismo naukowe
Tytuł:
Neuroprotective effect of herbal extracts inhibiting soluble epoxide hydrolase (sEH) and cyclooxygenase (COX) against chemotherapy-induced cognitive impairment in mice.
Autorzy:
Kulkarni R; Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru, 570015, India.
Mehta R; Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru, 570015, India.
Goswami SK; Department of Entomology and Nematology, UC Davis Comprehensive Cancer Center, University of California Davis, Davis, CA, United States.
Hammock BD; Department of Entomology and Nematology, UC Davis Comprehensive Cancer Center, University of California Davis, Davis, CA, United States.
Morisseau C; Department of Entomology and Nematology, UC Davis Comprehensive Cancer Center, University of California Davis, Davis, CA, United States.
Hwang SH; Department of Entomology and Nematology, UC Davis Comprehensive Cancer Center, University of California Davis, Davis, CA, United States.
Mallappa O; Discovery Sciences Group, R&D Centre, Himalaya Wellness Company, Makali, Bengaluru, 562162, India.
Azeemuddin MM; Discovery Sciences Group, R&D Centre, Himalaya Wellness Company, Makali, Bengaluru, 562162, India.
Rafiq M; Discovery Sciences Group, R&D Centre, Himalaya Wellness Company, Makali, Bengaluru, 562162, India.
S N M; Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru, 570015, India. Electronic address: .
Pokaż więcej
Źródło:
Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2023 Jul 30; Vol. 667, pp. 64-72. Date of Electronic Publication: 2023 May 03.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Neuroprotective Agents*/pharmacology
Neuroprotective Agents*/therapeutic use
Chemotherapy-Related Cognitive Impairment*
Nootropic Agents*
Humans ; Mice ; Animals ; Cyclooxygenase 2 ; Epoxide Hydrolases ; Inflammation
Czasopismo naukowe
Tytuł:
Age-related decline in hippocampal tyrosine phosphatase PTPRO is a mechanistic factor in chemotherapy-related cognitive impairment.
Autorzy:
Yao Z; Department of Urology Surgery, and.; Department of General Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, Guangdong, China.; Institute of Precision Cancer Medicine and Pathology, School of Medicine, Jinan University, Guangzhou, Guangdong, China.
Dong H; Institute of Precision Cancer Medicine and Pathology, School of Medicine, Jinan University, Guangzhou, Guangdong, China.
Zhu J; Department of General Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, Guangdong, China.; Institute of Precision Cancer Medicine and Pathology, School of Medicine, Jinan University, Guangzhou, Guangdong, China.
Du L; Institute of Precision Cancer Medicine and Pathology, School of Medicine, Jinan University, Guangzhou, Guangdong, China.
Luo Y; Institute of Precision Cancer Medicine and Pathology, School of Medicine, Jinan University, Guangzhou, Guangdong, China.
Liu Q; Department of Pathology, The First People's Hospital of Foshan, Foshan, Guangdong, China.
Liu S; Department of Thoracic Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, Guangdong, China.
Lin Y; Institute of Precision Cancer Medicine and Pathology, School of Medicine, Jinan University, Guangzhou, Guangdong, China.; Graduate School, Shantou University Medical College, Shantou, Guangdong, China.; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Wang L; Institute of Precision Cancer Medicine and Pathology, School of Medicine, Jinan University, Guangzhou, Guangdong, China.
Wang S; Institute of Precision Cancer Medicine and Pathology, School of Medicine, Jinan University, Guangzhou, Guangdong, China.
Wei W; Department of Pathophysiology, Key Laboratory of State Administration of Traditional Chinese Medicine of the People's Republic of China, School of Medicine, Jinan University, Guangzhou, Guangdong, China.
Zhang K; Department of Pathophysiology, Key Laboratory of State Administration of Traditional Chinese Medicine of the People's Republic of China, School of Medicine, Jinan University, Guangzhou, Guangdong, China.
Huang Q; Shantou University Mental Health Center.
Yu X; National Key Disciplines, Department of Forensic and Pathology, and.
Zhao W; Center for Neuroscience, Shantou University Medical College, Shantou, Guangdong, China.; Cell Biology Department, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
Xu H; Shantou University Mental Health Center.; The Affiliated Kangning Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Qiu X; Department of Urology, Guangdong Second Provincial General Hospital, Guangzhou, Guangdong, China.
Pan Y; Department of General Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, Guangdong, China.; Minister of Education Key Laboratory of Tumor Molecular Biology, Jinan University, Guangzhou, Guangdong, China.
Huang X; Gene Editing Center, School of Life Sciences and Technology, ShanghaiTech University, Shanghai, China.
Jim Yeung SC; Department of Emergency Medicine and Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Zhang D; Department of Biomedical Sciences, Philadelphia College of Osteopathic Medicine, Philadelphia, Pennsylvania, USA.
Zhang H; Department of General Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, Guangdong, China.; Institute of Precision Cancer Medicine and Pathology, School of Medicine, and Minister of Education Key Laboratory of Tumor Molecular Biology, Jinan University, Guangzhou, Guangdong, China.
Pokaż więcej
Źródło:
JCI insight [JCI Insight] 2023 Jul 24; Vol. 8 (14). Date of Electronic Publication: 2023 Jul 24.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Chemotherapy-Related Cognitive Impairment*
Animals ; Mice ; Hippocampus/metabolism ; Protein Tyrosine Phosphatases ; Protein-Tyrosine Kinases ; Tyrosine
Czasopismo naukowe
Tytuł:
The Ameliorative Effect of Pioglitazone against Neuroinflammation Caused by Doxorubicin in Rats.
Autorzy:
Alsaud MM; Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah 51452, Al Qassim, Saudi Arabia.
Alhowail AH; Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah 51452, Al Qassim, Saudi Arabia.
Aldubayan MA; Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah 51452, Al Qassim, Saudi Arabia.
Almami IS; Department of Biology, College of Science, Qassim University, Buraydah 51452, Al Qassim, Saudi Arabia.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2023 Jun 15; Vol. 28 (12). Date of Electronic Publication: 2023 Jun 15.
Typ publikacji:
Journal Article
MeSH Terms:
Neuroinflammatory Diseases*
Chemotherapy-Related Cognitive Impairment*
Rats ; Female ; Animals ; Pioglitazone/pharmacology ; Rats, Wistar ; Tumor Necrosis Factor-alpha/genetics ; Tumor Necrosis Factor-alpha/pharmacology ; Interleukin-6/genetics ; Interleukin-6/pharmacology ; Doxorubicin/pharmacology ; Cytokines/pharmacology ; Body Weight ; Oxidative Stress
Czasopismo naukowe
Tytuł:
A proof of concept phase II study with the PDE-4 inhibitor roflumilast in patients with mild cognitive impairment or mild Alzheimer's disease dementia (ROMEMA): study protocol of a double-blind, randomized, placebo-controlled, between-subjects trial.
Autorzy:
Possemis, Nina (AUTHOR)
Verhey, Frans (AUTHOR)
Prickaerts, Jos (AUTHOR)
Blokland, Arjan (AUTHOR)
Ramakers, Inez (AUTHOR)
Pokaż więcej
Źródło:
Trials. 3/4/2024, Vol. 25 Issue 1, p1-20. 20p.
Czasopismo naukowe
Tytuł:
Functional magnetic resonance imaging study during resting state and visual oddball task in mild cognitive impairment.
Autorzy:
Kemik, Kerem (AUTHOR)
Ada, Emel (AUTHOR)
Çavuşoğlu, Berrin (AUTHOR)
Aykaç, Cansu (AUTHOR)
Emek‐Savaş, Derya Durusu (AUTHOR)
Yener, Görsev (AUTHOR)
Pokaż więcej
Źródło:
CNS Neuroscience & Therapeutics. Feb2024, Vol. 30 Issue 2, p1-9. 9p.
Czasopismo naukowe
Tytuł:
An Examination of the Motives for Attributing and Interpreting Deception in People with Amnestic Mild Cognitive Impairment.
Autorzy:
Tilkeridou, Maria (AUTHOR)
Moraitou, Despina (AUTHOR)
Papaliagkas, Vasileios (AUTHOR)
Frantzi, Nikoleta (AUTHOR)
Emmanouilidou, Evdokia (AUTHOR)
Tsolaki, Magdalini (AUTHOR)
Pokaż więcej
Źródło:
Journal of Intelligence. Feb2024, Vol. 12 Issue 2, p12. 14p.
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies